You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Austria

May 2011

Price: US$2,400

About this Report

About this Report

Samples (FAQs about samples):

doc_pdf.png Sample Consumer Health Market Research Report

doc_excel_table.png Sample Consumer Health Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Austria with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Austria, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Austria for free:

The Consumer Health in Austria market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Austria?
  • What are the major brands in Austria?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Sample Analysis

EXECUTIVE SUMMARY

Dynamic growth within consumer health

Consumer health recorded dynamic growth in 2010, with sales being fuelled by the increasing popularity of self-medication and the growing use of consumer health products in order to prevent health problems. The areas that fuelled growth were ear care, digestive remedies based on proton pump inhibitors and laxatives, eye care, and vitamins and dietary supplements (especially eye health supplements, glucosamine, red clover, and fish oils). The worst performing areas were: other slimming products (due to declining consumer trust), cough remedies (due to warm winter weather), and cod liver oil (due to increasing competition from omega 3-6-9 tablets which are considered to taste better and offer similar benefits).

Obesity and cosmetic positioned products targeted towards over 50-year-olds

Consumers over the age of 50 remain an important target group for consumer health as demand for products within areas like hair loss treatments, eye health supplements, and sports nutrition is high amongst such consumers. In addition, it should be noted that the fact that the obesity epidemic is driving demand for products within areas like OTC obesity could result in a decline in demand for digestive remedies and vitamins and dietary supplements. Within areas like medicated skin care and weight management, companies are positioning their products as offering cosmetic benefits in order to attract consumers.

Bayer Austria leads highly fragmented consumer health

Bayer Austria leads highly fragmented consumer health in Austria due to its high brand recognition and presence in a diverse range of areas. Sanova Pharma, Gebro Pharma, and Boehringer Ingelheim are also performing well for similar reasons. Herbalife International Deutschland is the best ranked non-pharmaceutical company due to its strength within weight management and vitamins and dietary supplements. Kwizda Pharma is the leading domestic company, offering a range of products exclusively available within pharmacies.

Pharmacies + internet ? online pharmacies

Chemists/pharmacists was the leading consumer health channel in Austria in 2010, with pharmacists continuing to have a strong impact on determining consumer choice. Pharmacies lead OTC sales, accounting for around half of all vitamins and dietary supplements sales in Austria. However, it should be noted that internet retailing consumer health retail value sales increased by 12% during 2010. Whilst online pharmacies do operate in Austria, OTC products can only be ordered online and have to be collected in-store.

Slow growth forecasted

Consumer health turnover is expected to grow at a stable but slow rate over the forecast period. Whilst smaller areas such as glucosamine, eye health supplements, OTC obesity, red clover, and emergency contraception are likely to experience very dynamic growth until 2015, products within vitamins and dietary supplement fad areas such as cranberry, red wine leaves, cod liver oil, and fibre are expected to lose popularity due to increasing competition from even newer areas.

Table of Contents

Table of Contents

Consumer Health in Austria - Industry Overview

EXECUTIVE SUMMARY

Dynamic growth within consumer health

Obesity and cosmetic positioned products targeted towards over 50-year-olds

Bayer Austria leads highly fragmented consumer health

Pharmacies + internet ? online pharmacies

Slow growth forecasted

KEY TRENDS AND DEVELOPMENTS

Important but changing role of pharmacists

Internet retailing distribution channel facing difficulties

Producers increasingly targeting over 50 year-olds

Cosmetic consumer health products

Eating disorders and obesity affecting different consumer health areas

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2005-2010
  • Table 2 Life Expectancy at Birth 2005-2010

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2005-2010
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2005-2010
  • Table 5 Consumer Health Company Shares by Value 2006-2010
  • Table 6 Consumer Health Brand Shares by Value 2007-2010
  • Table 7 Penetration of Private Label by Category 2005-2010
  • Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
  • Table 9 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 10 Forecast Sales of Consumer Health by Category: Value 2010-2015
  • Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventative medicine

Switches

  • Summary 1 OTC Healthcare Switches 2008-2010

DEFINITIONS

  • Summary 2 Research Sources

Consumer Health in Austria - Company Profiles

Apomedica GmbH & Co KG in Consumer Health (Austria)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 5 Apomedica GmbH & Co KG: Competitive Position 2010

Firma Magister Martin Doskar Pharm Produkte eu in Consumer Health (Austria)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 7 Firma Magister Martin Doskar pharm. Produkte e.u.: Competitive Position 2010

Kwizda Pharma GmbH in Consumer Health (Austria)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 10 Kwizda Pharma GmbH: Competitive Position 2010

Natural Power GmbH in Consumer Health (Austria)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 13 Natural Power GmbH: Competitive Position 2010

Wellness Co GesmbH, The in Consumer Health (Austria)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 15 Wellness Co GesmbH: Competitive Position 2010

Adult Mouth Care in Austria - Category Analysis

HEADLINES

TRENDS

  • The fact that healthy teeth are considered a status symbol in Austria and a sign of overall health continues to fuel demand for adult mouth care products. Fillings that are not white, mainly amalgam, have been revealed as potentially dangerous for health and are increasingly being replaced. Cheap but high quality teeth treatments are available in neighbouring countries such as Hungary where a visit to the dentist can be combined with spa vacations.

COMPETITIVE LANDSCAPE

  • GlaxoSmithKline Pharma and CSC Pharmaceuticals Handels dominate adult mouth care sales in Austria, recording respective retail value shares of 23% and 21% in 2010. GlaxoSmithKline Pharma’s leading brand is Chlorhexamed whilst CSC Pharmaceuticals Handels’ leading brand is Tantum Verde.

PROSPECTS

  • Over the forecast period, specialised tooth care products are expected to cannibalise sales from adult mouth care. Adult mouth care products are often considered to be cosmetic products, with many consumers using mouth washes interchangeably with adult mouth care washes. However, beauty products enjoy greater visibility and advertising support and are therefore likely to record an increase in sales at the expense of adult mouth care over the coming years.

CATEGORY DATA

  • Table 12 Sales of Adult Mouth Care: Value 2005-2010
  • Table 13 Sales of Adult Mouth Care: % Value Growth 2005-2010
  • Table 14 Adult Mouth Care Company Shares by Value 2006-2010
  • Table 15 Adult Mouth Care Brand Shares by Value 2007-2010
  • Table 16 Forecast Sales of Adult Mouth Care: Value 2010-2015
  • Table 17 Forecast Sales of Adult Mouth Care: % Value Growth 2010-2015

Analgesics in Austria - Category Analysis

HEADLINES

TRENDS

  • Consumers are increasingly informed about the availability of different types of analgesics and what types of pain they are designed to treat. For example, many consumers take Aspirin when suffering from a headache or fever whilst preferring Ibuprofen for calming pain caused by injuries associated with bleeding.

COMPETITIVE LANDSCAPE

  • Bayer Austria led analgesics sales in 2010, recording a retail value share of 19%, and was closely followed by Boehringer Ingelheim. Bayer Austria’s success can be attributed to the popularity of its Bayer Aspirin, Aleve, and Aktren brands. However, the most popular analgesics brand is Boehringer’s Thomapyrin which recorded a retail value share of 17% in 2010.

PROSPECTS

  • Analgesics has a projected forecast period constant retail value CAGR of 1%, with sales expected to reach EUR60 million by 2015 and demand being boosted by the fact that an estimated 1.5 million over 16 year-olds in Austria suffer from chronic pain and that a growing number of consumers are struggling to cope with the increasingly hectic pace of modern life.

CATEGORY DATA

  • Table 18 Sales of Analgesics by Category: Value 2005-2010
  • Table 19 Sales of Analgesics by Category: % Value Growth 2005-2010
  • Table 20 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2005-2010
  • Table 21 Analgesics Company Shares by Value 2006-2010
  • Table 22 Analgesics Brand Shares by Value 2007-2010
  • Table 23 Forecast Sales of Analgesics by Category: Value 2010-2015
  • Table 24 Forecast Sales of Analgesics by Category: % Value Growth 2010-2015

Calming and Sleeping in Austria - Category Analysis

HEADLINES

TRENDS

  • As in most Western countries, the pace of modern life in Austria is becoming increasingly hectic – a development that is having a negative impact on emotional health with the number of people suffering from nervous conditions, insomnia, and emotional imbalances increasing. This trend, alongside the impact of the global recession, is fuelling demand for anti-stress and relaxation remedies such as calming and sleeping products.

COMPETITIVE LANDSCAPE

  • Sanova Pharma led calming and sleeping products in 2010, recording a retail value share of 18% due to the popularity of its Baldrian Sanova Nacht and Baldrian Sanova Nerven brands. Gebro Pharma, which produces Hova, ranked second with a retail value share of 16% and was followed by Austroplant Arzneimittel (15%) which produces Passedan and Vitango.

PROSPECTS

  • Over the forecast period, therapies with psychologists and psychiatrists are likely to become more accepted as emotional problems are increasingly recognised as being serious medical conditions.

CATEGORY DATA

  • Table 25 Sales of Calming and Sleeping: Value 2005-2010
  • Table 26 Sales of Calming and Sleeping: % Value Growth 2005-2010
  • Table 27 Calming and Sleeping Company Shares by Value 2006-2010
  • Table 28 Calming and Sleeping Brand Shares by Value 2007-2010
  • Table 29 Forecast Sales of Calming and Sleeping: Value 2010-2015
  • Table 30 Forecast Sales of Calming and Sleeping: % Value Growth 2010-2015

Cough, Cold and Allergy (Hay Fever) Remedies in Austria - Category Analysis

HEADLINES

TRENDS

  • Warmer than expected winter weather had a negative impact on demand for cough, cold and allergy (hay fever) remedies in 2010, with current retail value sales falling by 2%. In contrast, allergy care recorded a 5% increase in current retail value sales over the review period.

COMPETITIVE LANDSCAPE

  • Procter & Gamble Austria led sales in 2010, with its Wick brand accounting for some 13% of retail value sales, and was followed by, Novartis owned, Gebro Pharma (9%) which produces a range of different brands including: Otrivin, Lemocin, Vibrocil, and Halset. Bayer Austria and Plagemann Lebensmittelhandels ranked third and fourth respectively, each recording a retail value share of 7%. Bayer Austria’s retail value share can be attributed to the popularity of its Bayer Aspirin brand whilst Plagemann Lebensmittelhandels ranked fourth due to the popularity of its Ricola brand.

PROSPECTS

  • Cough, cold and allergy remedies has a projected forecast period constant retail value CAGR of -1%, with sales expected to fall to EUR116 million by 2010. The fact that winters over the coming years are expected to be relatively warm will have a negative impact on sales. However, allergy remedies sales will continue to rise due to the growing number of people suffering from sensitivity to environmental allergens.

CATEGORY DATA

  • Table 31 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 32 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 33 Sales of Decongestants by Category: Value 2005-2010
  • Table 34 Sales of Decongestants by Category: % Value Growth 2005-2010
  • Table 35 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 36 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 37 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2006-2010
  • Table 38 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2007-2010
  • Table 39 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2010-2015
  • Table 40 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2010-2015

Digestive Remedies in Austria - Category Analysis

HEADLINES

TRENDS

  • As a result of the increasingly stressful and hectic pace of modern life, the number of Austrian consumers suffering from digestive health problems is on the rise – a development that is helping to boost demand for digestive remedies. Demand for diarrhoeal remedies and laxatives is growing particularly fast and is fuelling overall growth. People leading busy lifestyles are often quick to use OTC medication as even minor digestive problems can significantly interfere with work performance.

SWITCHES

COMPETITIVE LANDSCAPE

  • Boehringer Ingelheim led digestive remedies sales in 2010, recording a retail value share of 11% due to the popularity of its Dulcolax and Guttalax brands. Bayer Austria - which produces Rennie, Talcid, Alka-Seltzer, and Lefaxin – ranked a close second whilst Janssen-Cilag Pharma ranked third with a retail value share of 4%.

PROSPECTS

  • Digestive remedies has a projected forecast period constant retail value CAGR of 2%, with sales expected to reach EUR52 million by 2015. Demand over the coming years will be fuelled by the increasingly hectic pace of modern life in Austria. Although consumers are trying to adopt healthier diets, the fact that they will continue to eat too fast whilst under stress will have a negative impact on their digestive health.

CATEGORY DATA

  • Table 41 Sales of Digestive Remedies by Category: Value 2005-2010
  • Table 42 Sales of Digestive Remedies by Category: % Value Growth 2005-2010
  • Table 43 Digestive Remedies Company Shares by Value 2006-2010
  • Table 44 Digestive Remedies Brand Shares by Value 2007-2010
  • Table 45 Forecast Sales of Digestive Remedies by Category: Value 2010-2015
  • Table 46 Forecast Sales of Digestive Remedies by Category: % Value Growth 2010-2015

Ear Care in Austria - Category Analysis

HEADLINES

TRENDS

  • Ear care products continue to increase in popularity, with a growing number of consumers shifting away from cotton buds and swabs. Whilst cotton buds and swabs are used to clean the outer ear of wax, physicians recommend the use of ear care products for cleaning the inner ear.

COMPETITIVE LANDSCAPE

  • Sigmapharm Arzneimittel dominated ear care in 2010, recording a retail value share of 78%, with the remaining value share within the area being distributed between a large number of smaller players. Whilst Sigmapharm Arzneimittel produces a wide range of OTC products, it is mainly known for its OTC ear care products.

PROSPECTS

  • As a result of rising interest in inner ear hygiene products, ear care constant retail value sales are projected to increase at an average annual rate of 4% over the forecast period to reach EUR1.4 million by 2015 - five percentage points lower than the review period average of 9%. Whilst ear care is likely to see an influx of additional consumers, the area is experiencing saturation in value terms.

CATEGORY DATA

  • Table 47 Sales of Ear Care: Value 2005-2010
  • Table 48 Sales of Ear Care: % Value Growth 2005-2010
  • Table 49 Ear Care Company Shares by Value 2006-2010
  • Table 50 Ear Care Brand Shares by Value 2007-2010
  • Table 51 Forecast Sales of Ear Care: Value 2010-2015
  • Table 52 Forecast Sales of Ear Care: % Value Growth 2010-2015

Emergency Contraception in Austria - Category Analysis

HEADLINES

TRENDS

  • The switch of emergency contraception products from Rx to OTC was unexpected by industry players and consumers, especially since Austria is a rather conservative and Catholic country. In addition, it should be noted that the relatively affordable unit price of EUR12 for emergency contraception products in the country is significantly lower than the USD30-40 charged in the US.

SWITCHES

COMPETITIVE LANDSCAPE

  • Sanova Pharma accounted for 100% of emergency contraception sales in 2010 due to the fact that it is currently the only company operating within the area. The company’s Vikela brand is based on the active ingredient Levonorgestrel and retails at EUR12 per unit. The product has potential side-effects and is said to be effective in preventing pregnancy in 70-80% of cases where conception has occurred.

PROSPECTS

  • OTC emergency contraception has a projected forecast period constant retail value CAGR of 6%, with sales expected to reach EUR16 million by 2015. With the liberalisation of emergency contraception, it is likely that consumers will purchase such products at their local pharmacy rather than going to a hospital or gynaecologist. In addition, it is possible that consumers from neighbouring countries will come to Austria in order to stock-up on emergency contraception products.

CATEGORY DATA

  • Table 53 Sales of Emergency Contraception: Value 2010
  • Table 54 Emergency Contraception Company Shares by Value 2006-2010
  • Table 55 Emergency Contraception Brand Shares by Value 2007-2010
  • Table 56 Forecast Sales of Emergency Contraception: Value 2010-2015
  • Table 57 Forecast Sales of Emergency Contraception: % Value Growth 2010-2015

Eye Care in Austria - Category Analysis

HEADLINES

TRENDS

  • The fact that consumers are spending more and more time before computers, TVs, smartphones, and other gadgets is negatively affecting eye health. In addition, longer working hours, hectic lifestyles, and the fact that the Austrian population is ageing is also fuelling demand for eye health products.

COMPETITIVE LANDSCAPE

  • Alcon Ophtalmika led eye care sales in 2010, recording a retail value share of 15%, and was followed by Boehringer Ingelheim. Alcon Ophtalmika and Boehringer Ingelheim’s success can be attributed to the popularity of their respective Protagent and Visadron brands.

PROSPECTS

  • Eye care has a projected forecast period constant retail value CAGR of 4%, with sales expected to reach EUR5 million by 2015 and demand being fuelled by the fact that a growing number of consumers are switching from Rx to OTC eye care. The most regular eye care consumers are contact lens users. Standard eye care has a projected forecast period constant retail value CAGR of 5% while allergy eye care has a projected forecast period constant retail value CAGR of 2%. Demand in these areas over the coming years will be fuelled by the fact that a growing number of consumers are shifting towards OTC medication as opposed to Rx eye care.

CATEGORY DATA

  • Table 58 Sales of Eye Care by Category: Value 2005-2010
  • Table 59 Sales of Eye Care by Category: % Value Growth 2005-2010
  • Table 60 Standard Eye Care by Type: % Value Breakdown 2007-2010
  • Table 61 Eye Care Company Shares by Value 2006-2010
  • Table 62 Eye Care Brand Shares by Value 2007-2010
  • Table 63 Forecast Sales of Eye Care by Category: Value 2010-2015
  • Table 64 Forecast Sales of Eye Care by Category: % Value Growth 2010-2015

Herbal/Traditional Products in Austria - Category Analysis

HEADLINES

TRENDS

  • Herbal/traditional products recorded current retail value growth of 3% in 2010 with sales reaching EUR102 million. Consumers are increasingly self-treating with OTC medication. However, as a first step most Austrians look to use traditional/herbal products as such products are perceived as being extremely safe.

COMPETITIVE LANDSCAPE

  • Plagemann Lebensmittelhandels led sales in 2010, recording a retail value share of 9% due to the popularity of its Ricola brand and was closely followed by Procter & Gamble Austria (9%), which produces the Wick candies range, Sanova Pharma (8%), and Kwizda Pharma (6%). Sanova Pharma’s share is based on sales of its Prospan and Baldrian Sanova Nerven brands whilst Kwizda Pharma’s most popular herbal/traditional product is Leaton.

PROSPECTS

  • Herbal/traditional products has a projected forecast period constant retail value CAGR of 1%, with sales expected to reach EUR107 million by 2015 and demand being fuelled by the growing number of people looking to prevent health problems by taking such products.

CATEGORY DATA

  • Table 65 Sales of Herbal/Traditional Products: Value 2005-2010
  • Table 66 Sales of Herbal/Traditional Products: % Value Growth 2005-2010
  • Table 67 Herbal/Traditional Products Company Shares 2006-2010
  • Table 68 Herbal/Traditional Products Brand Shares 2007-2010
  • Table 69 Forecast Sales of Herbal/Traditional Products: Value 2010-2015
  • Table 70 Forecast Sales of Herbal/Traditional Products: % Value Growth 2010-2015

Medicated Skin Care in Austria - Category Analysis

HEADLINES

TRENDS

  • In addition to treating any skin ailments, consumers increasingly expect medicated skin care products to also perform like skin care products. As a result, brands are increasingly designed for specific skin types and offer additional properties such as moisturising in order to help make skin look more radiant and youthful.

COMPETITIVE LANDSCAPE

  • Reckitt Benckiser Austria led medicated skin care in 2010, recording a retail value share of 17% due to the success of its acne treatment brand Clearasil whilst Bayer Austria, which produces the Bepanthen brand and antifungal product Canesten, ranked second with a retail value share of 12%. Gebro Pharma ranked third with a retail value share of 10% due to the popularity of its Vitawund, Fenistil, Exoderil, Euceta and Wundesin brands.

PROSPECTS

  • Medicated skin care will continue to record stable growth over the forecast period due to rising demand in the area. All medicated skin care product areas are expected to record positive growth over the forecast period with the exception of child-specific medicated skin care, nappy (diaper) rash treatments, haemorrhoid treatments, topical germicidals/antiseptics, and topical antifungals.

CATEGORY DATA

  • Table 71 Sales of Medicated Skin Care by Category: Value 2005-2010
  • Table 72 Sales of Medicated Skin Care by Category: % Value Growth 2005-2010
  • Table 73 Acne Treatments by Format: % Value Breakdown 2005-2010
  • Table 74 Medicated Skin Care Company Shares by Value 2006-2010
  • Table 75 Medicated Skin Care Brand Shares by Value 2007-2010
  • Table 76 Acne Treatments Brand Shares by Value 2007-2010
  • Table 77 Hair Loss Treatments Brand Shares by Value 2007-2010
  • Table 78 Forecast Sales of Medicated Skin Care by Category: Value 2010-2015
  • Table 79 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2010-2015

NRT Smoking Cessation Aids in Austria - Category Analysis

HEADLINES

TRENDS

  • Rather than legal restrictions, the main motivation for the increasing use of NRT smoking cessation aids is rising consumer health consciousness. Although specific laws that protect non-smokers in restaurants and nightclubs were introduced during the review period, compliance with the regulations is very limited.

COMPETITIVE LANDSCAPE

  • There are currently only three players within NRT smoking cessation aids in Austria. Janssen-Cilag Pharma (owned by Johnson & Johnson) dominated sales in 2010, recording a retail value share of 85% due to the popularity of its Nicorette brand. Gebro Pharma, which is owned by Novartis and produces Nicotinell, ranked second with a retail value share of 14% and was followed by Dr A & L Schmidgall (1%) which produces the Nicobloc brand.

PROSPECTS

  • NRT smoking cessation aids has a projected forecast period constant retail value CAGR of 2%, with sales expected to reach EUR9 million by 2015 and demand being fuelled by rising consumer health awareness. In addition, the fact that overweight people are being encouraged to quit smoking by doctors is also helping to boost demand.

CATEGORY INDICATORS

  • Table 80 Number of Smokers by Gender 2005-2010

CATEGORY DATA

  • Table 81 Sales of NRT Smoking Cessation Aids by Category: Value 2005-2010
  • Table 82 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2005-2010
  • Table 83 NRT Gum Flavours: % Value Breakdown 2006-2010
  • Table 84 NRT Smoking Cessation Aids Company Shares by Value 2006-2010
  • Table 85 NRT Smoking Cessation Aids Brand Shares by Value 2007-2010
  • Table 86 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2010-2015
  • Table 87 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2010-2015

Sports Nutrition in Austria - Category Analysis

HEADLINES

TRENDS

  • Austrian consumers continue to become more active due to rising awareness of the importance of exercise for both health and pleasure. For example, a growing number of consumers are becoming members of gyms whilst older consumers with relatively high disposable incomes are also engaging in sport.

COMPETITIVE LANDSCAPE

  • Natural Power led sales in 2010, recording a retail value share of 23%, and was followed by Atlantic Multipower Germany (19%). The remainder of sales in the area were divided amongst less important players, with APOtrend Vertrieb ranking third with a retail value share of 8%. The fact that ‘others’ accounted for 36% of retail value sales highlights the fragmented nature of the area.

PROSPECTS

  • Sports nutrition has a projected forecast period constant retail value CAGR of 2%, with sales expected to reach EUR15 million by 2015. Consumers will remain interested in sports nutrition due to increasing awareness of the importance of regular exercise and to optimise performance. Over the coming years, it is expected that consumers will increase their focus on endurance as opposed to building muscle mass.

CATEGORY DATA

  • Table 88 Sports Nutrition, Category Rankings 2010
  • Table 89 Sales of Sports Nutrition: Value 2005-2010
  • Table 90 Sales of Sports Nutrition: % Value Growth 2005-2010
  • Table 91 Sports Nutrition By Format: % Value Breakdown 2007-2010
  • Table 92 Sports Nutrition Company Shares 2006-2010
  • Table 93 Sports Nutrition Brand Shares 2007-2010
  • Table 94 Forecast Sales of Sports Nutrition: Value 2010-2015
  • Table 95 Forecast Sales of Sports Nutrition: % Value Growth 2010-2015

Vitamins and Dietary Supplements in Austria - Category Analysis

HEADLINES

TRENDS

  • Consumers are becoming more and more responsible for their own health in order to increase work performance and enjoy life as much as possible. As a result, demand for preventative products such as vitamins/dietary supplements is rising. Consumers are open to trying new innovative products and are also interested in using dietary supplements when they feel the onset of specific illnesses.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • Bayer Austria led vitamins and dietary supplements in 2010, recording a retail value share of 15% due to the popularity of leading brands like Supradyn, Cal-C-Vita, and Biovital. GlaxoSmithKline, which produces Abtei and Cetebe, ranked second with a retail value share of 10% and was followed by Nycomed Pharma (6%) which produces the Buerlecithin brand.

PROSPECTS

  • Vitamins and dietary supplements has a projected forecast period constant retail value CAGR of 1%, with sales expected to reach EUR157 million by 2015. Consumers will continue to be attracted to vitamins and dietary supplements as they look to prevent health problems. However, the fact that a large number of ‘fad’ products will continue to be introduced within the area will have a limiting impact on growth.

CATEGORY DATA

  • Table 96 Dietary Supplements: Brand Ranking by Positioning 2010
  • Table 97 Sales of Vitamins and Dietary Supplements by Category: Value 2005-2010
  • Table 98 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2005-2010
  • Table 99 Dietary Supplements by Positioning 2005-2010
  • Table 100 Vitamins and Dietary Supplements Company Shares by Value 2006-2010
  • Table 101 Vitamins and Dietary Supplements Brand Shares by Value 2007-2010
  • Table 102 Vitamins Brand Shares by Value 2007-2010
  • Table 103 Dietary Supplements Brand Shares by Value 2007-2010
  • Table 104 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2010-2015
  • Table 105 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2010-2015

Weight Management in Austria - Category Analysis

HEADLINES

TRENDS

  • The only OTC obesity drug in Austria, GlaxoSmithKline’s Alli, was introduced in 2009 and has helped to significantly boost weight management sales. OTC obesity drugs were only switched from Rx to OTC in mid-2009 and Alli remains the sole product available in this area. The brand is only available within pharmacies for consumers above a specific body mass index even if ordered online from foreign pharmacies.

COMPETITIVE LANDSCAPE

  • Herbalife International Deutschland dominates weight management in Austria, recording a retail value share of 67% in 2010 due to the popularity of its Herbalife meal replacement products and its strong direct sales network. GlaxoSmithKline ranked second with a retail value share of 6% due to the popularity of its Alli brand which is currently the only OTC obesity product available in Austria.

PROSPECTS

  • Weight management has a projected forecast period constant retail value CAGR of 0%, with sales expected to remain stable at EUR21 million until 2015. OTC obesity will fuel growth over the coming years, with constant retail value sales projected to increase at an average annual rate of 9% due to the popularity of the new Alli brand. Slimming teas is also expected to perform well, with a projected forecast period constant retail value CAGR of 3%. Slimming teas are naturally attracting consumers who already consume plenty of liquid in a bid to lose weight and who hope that slimming teas could provide further help.

CATEGORY DATA

  • Table 106 Sales of Weight Management: Value 2005-2010
  • Table 107 Sales of Weight Management: % Value Growth 2005-2010
  • Table 108 Weight Management Company Shares 2006-2010
  • Table 109 Weight Management Brand Shares 2007-2010
  • Table 110 Forecast Sales of Weight Management: Value 2010-2015
  • Table 111 Forecast Sales of Weight Management: % Value Growth 2010-2015

Wound Care in Austria - Category Analysis

HEADLINES

TRENDS

  • Consumers are increasingly demanding wound care products that provide additional cosmetic benefits. Ultimately, wound care brands are perceived as being skin care products since they are applied to the body. As a result, consumers are increasingly searching for wound care products that fit their specific skin type, are less visible, and ensure that no trace of the wound remains. For example, Beiersdorf recently introduced 100% transparent tape Hansaplast Protection.

COMPETITIVE LANDSCAPE

  • Wound care is dominated by Beiersdorf, which recorded a retail value share of 61% in 2010 due to the popularity of its Hansaplast and Leukoplast brands. The company was followed by 3M Österreich (10%) which produces Nexcare, Hartmann (5%) which produces Hartmann, Lohmann & Rauscher (2%) which produces Gazin and Suprasorb, and Kwizda Pharma (2%) which produces Erste Hilfe Spray.

PROSPECTS

  • Wound care has a projected forecast period constant retail value CAGR of 1%, with sales expected to reach EUR24 million by 2015. The fact that consumers are increasingly taking care of wounds that do not require surgical interventions themselves will continue to boost sales over the coming years.

CATEGORY DATA

  • Table 112 Sales of Wound Care by Category: Value 2005-2010
  • Table 113 Sales of Wound Care by Category: % Value Growth 2005-2010
  • Table 114 Wound Care Company Shares by Value 2006-2010
  • Table 115 Wound Care Brand Shares by Value 2007-2010
  • Table 116 Forecast Sales of Wound Care by Category: Value 2010-2015
  • Table 117 Forecast Sales of Wound Care by Category: % Value Growth 2010-2015

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Child-Specific Cough, Cold and Allergy Remedies
          • Child-Specific Allergy Remedies
          • Child-Specific Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Child-Specific Digestive Remedies
          • Child-Specific Diarrhoeal Remedies
          • Child-Specific Indigestion and Heartburn Remedies
          • Child-Specific Laxatives
          • Child-Specific Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Acne Treatments
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Child-Specific Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
    • Vitamins and Dietary Supplements
      • Child-Specific Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
            • Artichoke
            • Cranberry
            • Fibre
            • Isoflavones
            • Pumpkin Seed
            • Red Wine Leaves
            • Other Other Herbal/Traditional Dietary Supplements
        • Non-Herbal Dietary Supplements
          • Calcium Supplements
          • Co-Enzyme Q10
          • Combination Non-Herbal Dietary Supplements
          • Eye Health Supplements
          • Fish Oils
            • Cod Liver Oil
            • Other Fish Oils
          • Glucosamine
          • Mineral Supplements
          • Omega-3-6-9 (Fish and Non-Fish)
          • Probiotic Supplements
          • Protein Powder
          • Royal Jelly
          • Sam-E
          • Other Non-Herbal Dietary Supplements
            • NADH
            • Silica
      • Tonics and Bottled Nutritive Drinks
      • Vitamins
        • Multivitamins
        • Single Vitamins
          • Vitamin A
          • Vitamin B
          • Vitamin C
          • Vitamin D
          • Vitamin E
          • Other Single Vitamins
    • Weight Management
      • Meal Replacement Slimming
      • OTC Obesity
      • Slimming Teas
      • Weight Loss Supplements
      • Other Slimming Products
    • Herbal/Traditional Products
      • Herbal/Traditional Analgesics
      • Herbal/Traditional Calming and Sleeping Products
      • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
      • Herbal/Traditional Digestive Remedies
      • Herbal/Traditional Medicated Skin Care
      • Herbal/Traditional Medicinal Teas
      • Herbal/Traditional Smoking Cessation Aids
      • Herbal/Traditional Child-Specific Dietary Supplements
      • Herbal/Traditional Dietary Supplements
      • Herbal/Traditional Tonics and Bottled Nutritive Drinks
    • Allergy Care
      • Allergy Eye Care
      • Antihistamines/Allergy Remedies (Systemic)
      • Child-Specific Allergy Remedies
      • Topical Allergy Remedies/Antihistamines
    • Child-Specific Consumer Health
      • Child-Specific Analgesics
        • Child-Specific Acetaminophen
        • Child-Specific Aspirin
        • Child-Specific Combination Products - Analgesics
        • Child-Specific Diclofenac
        • Child-Specific Dipyrone
        • Child-Specific Ibuprofen
        • Child-Specific Ketoprofen
        • Child-Specific Naproxen
      • Child-Specific Cough, Cold and Allergy Remedies
        • Child-Specific Allergy Remedies
        • Child-Specific Cough/Cold Remedies
      • Child-Specific Digestive Remedies
        • Child-Specific Diarrhoeal Remedies
        • Child-Specific Indigestion and Heartburn Remedies
        • Child-Specific Laxatives
        • Child-Specific Motion Sickness Remedies
      • Child-Specific Medicated Skin Care
      • Nappy (Diaper) Rash Treatments
      • Child-Specific Vitamins and Dietary Supplements

Statistics Included

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market sizes
  • Company shares
  • Brand shares
  • Distribution
  • Analysis by format
  • Analysis by positioning
  • Analysis by type
  • Herbal/traditional vs standard
  • Pricing
  • Smoking incidence

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices % growth
  • Retail value retail selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices % growth
  • Retail value manufacturer selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices % growth
  • Retail value retail selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices % growth
  • Retail value manufacturer selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY

Methodology

Methodology

Global insight and local knowledge

With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

Industry specialists

Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

Country and regional analysts

Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

In-country research network

To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

Research Methodology

Our research methods

Each Euromonitor International industry report is based on a core set of research techniques:

Desk research

With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

  • National statistics offices governmental and official sources
  • National and international trade press
  • National and international trade associations
  • Industry study groups and other semi-official sources
  • Company financials and annual reports
  • Broker reports
  • Online databases
  • The financial, business and mainstream press

Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

Store checks

Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

  • Place: We track products in all relevant channels, selective and mass, store and non-store
  • Product: What are innovations in products, pack sizes and formats?
  • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
  • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

Trade survey

Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

Trade surveys allow us to:

  • Fill gaps in available published data per company
  • Generate a consensus view of the size, structure and strategic direction of the category
  • Access year-in-progress data where published sources are out of date
  • Evaluate the experts’ views on current trends and market developments

In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

Company analysis

At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

Forecasts

Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

Data validation

All data is subjected to an exhaustive review process, at country, regional and global levels.

The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

Market analysis

Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

my pages

Want to find out more about this report?

If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!

RELATED

Future Demographic

Country Report

Consumer Lifestyle

Country Report